Endostatin induces autophagy in endothelial cells by modulating Beclin 1 and beta-catenin levels.

Endostatin is a well-characterized endogenous inhibitor of angiogenesis that affects cell proliferation and migration by inhibiting integrin and Wnt-mediated signalling pathways. Here, we show that endothelial cells treated with native and P125A-endostatin activate autophagy. Because autophagy can either be protective or induce programmed cell death, experiments were carried out to ...
understand the signalling pathways leading to autophagy in endothelial cells. P125A-endostatin treatment increased the levels of Beclin 1, a crucial molecule in vesicle nucleation and autophagy. The treatment also reduced the levels of Bcl-2, Bcl-x(L) and beta-catenin; however, progressively increasing amounts of Bcl-2 and Bcl-x(L) were found to be complexed with Beclin 1. Increased beta-catenin and Wnt-mediated signalling reduced Beclin 1 levels and rescued endothelial cells from endostatin-induced autophagy. Finally, knocking down Beclin 1 levels by RNA interference decreased autophagy and accelerated caspase activation in endostatin-treated cells. These studies suggest that endothelial cells may initiate autophagy as a survival response to limit the effects of angiogenesis inhibitors. Thus, interfering with autophagy can potentiate the effects of endostatin by promoting a switch to apoptosis.
Mesh Terms:
Apoptosis Regulatory Proteins, Autophagy, Beclin-1, Caspases, Cell Line, Tumor, Endostatins, Endothelial Cells, Enzyme Activation, Gene Expression Regulation, Humans, Membrane Proteins, Phosphatidylinositol 3-Kinases, RNA Interference, Time Factors, Umbilical Veins, beta Catenin
J Cell Mol Med
Date: Sep. 01, 2009
Download Curated Data For This Publication
251586
Switch View:
  • Interactions 4